Guidelines

P28 Occurrence of high grade B-cell lymphoma with rearrangement of MYC and BCL2 and/or BCL6 under ruxolitinib: a case report

February 2019
P29 Unravelling the molecular landscape of post-transplant diffuse large B cell lymphoma

February 2019
P30 The identification of actionable genetic events driving disease progression and heterogeneity in peripheral T cell lymphoma, not otherwise specified

February 2019
P31 HLTV-1 associated adult T cell leukaemia-lymphoma (ATLL) presenting as cutaneous lymphoma: a case report

February 2019
P32 Belgian registry of breast implant-associated anaplastic large cell lymphoma

February 2019
P38 Donor and recipient developing JAK2 V617F positive myeloproliferative disease after stem cell transplantation: a case report

February 2019
P39 Mutational landscape of 109 MDS and 64 AML patients: a single-centre study

February 2019
P40 FIP1L1-PDGFRA P.T674I-D842L: a novel and ponatinib resistant compound mutation in FIP1L1-PDGFRA positive eosinophilic leukaemia

February 2019
P41 Impact of stopping tyrosine kinase inhibitor therapy on the molecular workload for monitoring: a single centre experience

February 2019
P42 The spectrum of related malignancies

February 2019

Top